Lights and Shadows of Bacillus Calmette-Guérin (BCG)-exposed and BCG-unresponsive Definitions: A Practical Overview

IF 9.3 1区医学 Q1 ONCOLOGY European urology oncology Pub Date : 2025-04-01 Epub Date: 2024-09-26 DOI:10.1016/j.euo.2024.09.010

Luca Afferi , Andrea Gallioli , Damiano Stracci , Agostino Mattei , Christian Fankhauser , Marco Moschini , Peter C. Black , Benjamin Pradere , Jorge Huguet Pérez , Oscar Rodriguez-Faba , Joan Palou , Alberto Breda

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

卡介苗（BCG）暴露和卡介苗无反应定义的光与影：实用概述。

根据目前对卡介苗（BCG）治疗后非肌层浸润性膀胱癌复发的定义，卡介苗暴露和晚期复发类别的患者可能会从进一步灌注中获益。对卡介苗无反应的患者可参加临床试验，但除此之外，根治性膀胱切除术是首选治疗方法。卡介苗不耐受的疾病仍是一个争论不休的领域，有关这些患者最佳治疗方法的证据有限。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

European urology oncology Multiple-

CiteScore

15.50

自引率

2.40%

发文量

128

审稿时长

20 days

期刊介绍： Journal Name: European Urology Oncology Affiliation: Official Journal of the European Association of Urology Focus: First official publication of the EAU fully devoted to the study of genitourinary malignancies Aims to deliver high-quality research Content: Includes original articles, opinion piece editorials, and invited reviews Covers clinical, basic, and translational research Publication Frequency: Six times a year in electronic format

期刊最新文献

Prostate Cancer Care for Men with an Intellectual Disability: A Population-based Cohort Study of Symptoms, Diagnosis, Treatment, and Survival. Re: Andrisha-Jade Inderjeeth, Andrew J Martin, Robert R Zielinski et al. Radiographic Progression Without Prostate-specific Antigen Progression in Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Analysis of the ENZAMET Trial (ANZUP 1304). Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.01.008. Extended Follow-up from the Stereotactic Body Radiotherapy for High-risk Localized Carcinoma of the Prostate (SHARP) Consortium: Updated Analysis of 440 Patients. Integrating Genomic Prostate Score with Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores to Predict Biochemical Recurrence after Radical Prostatectomy. Associations Between Quality of Life and Disease Progression in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials.